# Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

> **NCT00541840** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Grupo Espanol de Investigacion en Sarcomas** · enrollment: 24 (estimated)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00541840
- **Lead sponsor:** Grupo Espanol de Investigacion en Sarcomas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** 2009-04
- **Final completion:** 2010-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2008-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541840, "Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00541840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*